# Scholar Rock to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
Canonical URL: https://biopharmsignal.com/news/SRRK/scholar-rock-to-present-at-the-goldman-sachs-47th-annual-global-healthcare-conference
Ticker: SRRK
Company: Scholar Rock
Source: Scholar Rock
Published: 2026-06-25 13:46 EST
Original Source URL: https://investors.scholarrock.com
## Summary

CAMBRIDGE, Mass. --(BUSINESS WIRE)--May 26, 2026-- Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company dedicated to improving the lives of children and adults with spinal muscular atrophy (SMA) and additional rare, severe, and debilitating neuromuscular diseases by applying its leading

## Article Body
CAMBRIDGE, Mass. --(BUSINESS WIRE)--May 26, 2026-- Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company dedicated to improving the lives of children and adults with spinal muscular atrophy (SMA) and additional rare, severe, and debilitating neuromuscular diseases by applying its leading
## Recent Company News
- 2026-06-25 13:46 EST — [Scholar Rock to Showcase Neuromuscular Research Portfolio at 2026 Annual Cure SMA Research and Clinical Care Meeting and 2026 International Research Congress on FSHD](https://biopharmsignal.com/news/SRRK/scholar-rock-to-showcase-neuromuscular-research-portfolio-at-2026-annual-cure-sma-research-and-clinical-care-meeting-and-2026-international-research-congress-on-fshd) — Source: Scholar Rock
- 2026-06-25 13:46 EST — [Scholar Rock to Present at the Goldman Sachs 47th Annual Global Healthcare Conference](https://biopharmsignal.com/news/SRRK/scholar-rock-to-present-at-the-goldman-sachs-47th-annual-global-healthcare-conference) — Source: Scholar Rock
- 2026-06-25 13:46 EST — [Scholar Rock to Present at the 2026 Jefferies Global Healthcare Conference](https://biopharmsignal.com/news/SRRK/scholar-rock-to-present-at-the-2026-jefferies-global-healthcare-conference) — Source: Scholar Rock
- 2026-06-25 13:46 EST — [Scholar Rock Reports First Quarter 2026 Financial Results and Recent Business Highlights](https://biopharmsignal.com/news/SRRK/scholar-rock-reports-first-quarter-2026-financial-results-and-recent-business-highlights) — Source: Scholar Rock
- 2026-06-25 13:46 EST — [Scholar Rock to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026](https://biopharmsignal.com/news/SRRK/scholar-rock-to-report-fourth-quarter-and-full-year-2025-financial-results-on-march-3-2026) — Source: Scholar Rock
## Related News
- 2026-07-21 12:00 EST — MOR — [Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed](https://biopharmsignal.com/news/MOR/novartis-delivered-sales-growth-in-q2-and-further-advanced-the-pipeline-full-yea-63a32b47)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)
- 2026-07-20 13:05 EST — ACAD — [Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis](https://biopharmsignal.com/news/ACAD/acadia-pharmaceuticals-receives-fda-fast-track-designation-for-remlifanserin-in--f36b622c)
- 2026-07-20 13:00 EST — ENLV — [Enlivex Treasury Portfolio Update: NAV Per Ordinary Share $66.16; Total Treasury Holdings Valued at Approximately $1.1 Billion](https://biopharmsignal.com/news/ENLV/enlivex-treasury-portfolio-update-nav-per-ordinary-share-66-16-total-treasury-ho-9d036ef9)